Sign Out
Betahistine should not be given to patients with phaeochromocytoma. It should be given with care to patients with asthma, peptic ulcer disease or a history of peptic ulcer disease.
Betahistine is considered to be unsafe in patients with porphyria because it has been shown to be porphyrinogenic in in-vitro systems.
Continue with Google